Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-10

Generation of mice transgenic for killer cell hla class i receptors

Objective



Research objectives and contents
NK cells express on their surface receptors for MHC class I proteins (KIR). Engagement of these receptors inhibits NK cell cytotoxic programs. KIR can be expressed on T cell subsets and their engagement also results in inhibition of effector functions by the CD3-TCR complex. The aim of my proposal is to investigate the mechanisms of activation and/or inhibition of natural cytotoxicity with an "in vivo" model. In particular I would like to generate mice transgenic for a class of KIR, the p58 molecules and their natural mutant p50, which specifically recognize HLA-Cw3. The transgenic mice for p58/p50 molecules will be a unique model for the study of KIR role in NK cell ontogeny of the repertoire of NK cells in these mice and of the dissection of the mechanisms controlling T and NK cell activation/inhibition programs.
Training content (objective, benefit and expected impact)
My project is a part of a collaboration on NK receptors for MHC class I molecules-between the laboratory directed by Prof. L. Moretta in Italy and the one directed by Prof. E. Vivier in France. Since the Centre d'Immunologie de Marseille-Luminy has a long experience in "in vivo'' investigation using transgenic mice, I will easily conduct my project and I will be able to learn a highly specialized technique than can be very useful for my professional experience.
Links with industry / industrial relevance (22)

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Institut National de la Santé et de la Recherche Médicale (INSERM)
EU contribution
No data
Address
Parc Scientifique de Luminy
13288 Marseille
France
Total cost
No data

Participants (1)